These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4109017)

  • 1. Effect of exposure to lindane on drug metabolism: decreased hexobarbital sleeping-times and increased antipyrine disappearance rate in rats.
    Kolmodin-Hedman B; Alexanderson B; Sjöqvist F
    Toxicol Appl Pharmacol; 1971 Nov; 20(3):299-307. PubMed ID: 4109017
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of urea on hexobarbital and antipyrine disposition in rats.
    Valentovic M; Bachmann K
    Pharmacology; 1980; 21(3):167-74. PubMed ID: 7413718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE; Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract]   [Full Text] [Related]  

  • 4. Hexobarbital sleeping time in male rats with hepatic injury.
    Varga F; Fischer E
    Acta Physiol Acad Sci Hung; 1969; 36(4):431-9. PubMed ID: 5376036
    [No Abstract]   [Full Text] [Related]  

  • 5. Increase of hexobarbital sleeping time and inhibition of drug metabolism by the major metabolite of diphenylhydantoin.
    Stavchansky SA; Lubawy WC; Kostenbauder HB
    Life Sci; 1974 Apr; 14(8):1535-9. PubMed ID: 4829543
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of estrus cycle on drug metabolism in the rat.
    Brandstetter Y; Kaplanski J; Leibson V; Ben-Zvi Z
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):251-4. PubMed ID: 3582419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatic drug metabolism by cyclic 3',5'-adenosine monophosphate.
    Weiner M; Buterbaugh GG; Blake DA
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):249-63. PubMed ID: 4372659
    [No Abstract]   [Full Text] [Related]  

  • 8. Cannabinoids and hexobarbital induced loss of righting reflexes.
    Fernandes M; Kluwe S; Coper H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(4):431-5. PubMed ID: 4278425
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of subchronic treatment with (-) 8 -trans-tetrahydrocannabinol ( 8 -THC) on food intake, body temperature, hexobarbital sleeping time and hexobarbital elimination in rats.
    Rating D; Broermann I; Honecker H; Kluwe S; Coper H
    Psychopharmacologia; 1972; 27(4):349-57. PubMed ID: 4648618
    [No Abstract]   [Full Text] [Related]  

  • 11. Antipyrine, theophylline, and hexobarbital as in vivo P450 probe drugs.
    Groen K; Breimer DD
    Methods Enzymol; 1996; 272():169-77. PubMed ID: 8791775
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of the enantiomers of hexobarbital studied in the same intact rat and in the same isolated perfused rat liver.
    Breimer DD; van Rossum JM
    Eur J Pharmacol; 1974 May; 26(2):321-30. PubMed ID: 4853606
    [No Abstract]   [Full Text] [Related]  

  • 13. Hexobarbital action in rats with flavonoid-deficiency.
    Endell W; Seidel G
    Experientia; 1976 Sep; 32(9):1189-90. PubMed ID: 971760
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of low protein diet on sleeping time and on the metabolism of hexobarbital in rats.
    Czyzewska-Szafran H; Lastowska K; Obojska K; Wutkiewicz M
    Pol J Pharmacol Pharm; 1975; 27(6):625-30. PubMed ID: 1208235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of brain sensitivity and hepatic metabolism of hexobarbitone to dose-response relations in infant and young rats.
    Kalser SC; Forbes E; Kunig R
    J Pharm Pharmacol; 1969 Feb; 21(2):109-13. PubMed ID: 4388087
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sleeping time and awaking blood concentration of hexobarbital influenced by glucose and adrenaline in rats of both sexes].
    Wenzlik R; Klinger W
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):155-61. PubMed ID: 999395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonspecific effect of bis(2-ethylhexyl) phthalate on hexobarbital sleep time.
    Swinyard EA; Woodhead JH; Petersen RV
    J Pharm Sci; 1976 May; 65(5):733-4. PubMed ID: 932943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of rifampicin on the metabolic clearance of galactose and antipyrine as compared with hexobarbital].
    Zilly W; Wernze H; Buchenau D; Breimer DD; Richter E
    Verh Dtsch Ges Inn Med; 1975; 81():1677-80. PubMed ID: 1227056
    [No Abstract]   [Full Text] [Related]  

  • 19. Interference of hepatic drug metabolism in Plasmodium berghei-infected mice and its therapeutic modification: A study of hexobarbital sleeping time and phenobarbital-induced liver stimulation.
    Einheber A; Wren RE; Klobukowski CJ
    Exp Parasitol; 1970 Jun; 27(3):424-43. PubMed ID: 5419453
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on some possible mechanisms of potentiation of hexobarbital hypnosis by pilocarpine, muscarine and arecoline.
    Tsujimoto A; Doi T; Ikeda M; Nishikawa T
    Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):264-73. PubMed ID: 4447408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.